Charles R Drew University Master of Science and Clinical Research Program
Charles R Drew University Master of Science and Clinical Research Program
批准号:
7270465
负责人:
THOMAS Toyokazu YOSHIKAWA
金额:
$48.42万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2011-07-30
关键词:
Academic Medical CentersAccountingAddressAdministratorAdmission activityAffectAfrican AmericanAmericanAmerican Heart AssociationAnalysis of VarianceAppendixApplications GrantsAppointmentAreaAsian IndianAsiansAttentionAwardAwarenessBasic ScienceBibliographyBiomedical ResearchBiometryBudgetsCaringCase StudyCase-Control StudiesCharacteristicsChi-Square TestsClassClimateClinicalClinical ResearchClinical ServicesClinical TrialsClinical Trials DesignCohort StudiesCollaborationsCommitCommunicationCommunitiesCompetenceComplexConditionConfidence IntervalsConflict (Psychology)ConsentConsent FormsConsultationsCounty HospitalsCritiquesCross-Sectional StudiesDataData CollectionDatabasesDecision MakingDentistryDepthDevelopmentDiabetes MellitusDiagnosticDisadvantagedDisciplineDiscipline of NursingDiseaseDisease OutcomeDisease regressionDoctor of MedicineDoctor of PhilosophyEducationEducational CurriculumEducational process of instructingEducational workshopElementsEligibility DeterminationEndowmentEnrollmentEnsureEnvironmentEpidemiologyEquilibriumEthical IssuesEthicsEtiologyEvaluationExerciseExposure toFacultyFellowship ProgramFoundationsFundingGenderGenetic Crossing OverGenetic ResearchGoalsGraduate EducationGrantHealthHealth PersonnelHealth Services ResearchHealthcareHealthy People 2010HispanicsHourHuman ResourcesIndividualInstitutionInsurance CoverageInterviewJournalsKnowledgeLearningLettersLibrariesLifeLinkLiteratureLongitudinal StudiesLos AngelesManuscriptsMaster of ScienceMaster&aposs DegreeMeasuresMechanicsMedicineMentorsMentorshipMethodologyMethodsMiningMinorityMinority-Serving InstitutionMissionMolecularMolecular BiologyMonitorMorbidity - disease rateN(delta)-acetylornithine, -isomerN-dodecanoylglutamic acid, -isomer, sodium saltNCI Scholars ProgramNational Center for Research ResourcesNatureNeuro-Oncological Ventral Antigen 2New YorkNon-Citizen NationalNumbersOdds RatioOperative Surgical ProceduresOutcomeOutcomes ResearchPan GenusParticipantPatientsPersonal SatisfactionPharmaceutical PreparationsPhasePhysiciansPilot ProjectsPopulationPopulation HeterogeneityPositioning AttributePostdoctoral FellowPrincipal InvestigatorProceduresProcessProductivityProtocols documentationPublicationsPurposeQualifyingQuality of lifeRaceRandomizedRangeRateReadingRecommendationRecruitment ActivityRegulationRelative (related person)ReportingResearchResearch DesignResearch EthicsResearch Ethics CommitteesResearch InfrastructureResearch MethodologyResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResearch TrainingResourcesReview LiteratureRewardsRoleSample SizeSamplingSchemeScienceScientistServicesSex BehaviorSolidSourceStandards of Weights and MeasuresStructureStudentsSubjects SelectionsSurveysTechniquesTestingTextbooksTherapeuticTimeTrainingTranslatingTranslational ResearchUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States National Institutes of HealthUniversitiesVulnerable PopulationsWagesWeekWolvesWomanWorkWritingalpha-difluoromethyl-DOPA, -isomeralpha-methylornithine dihydrochloride, -isomerbasecareercollegecomparison groupconceptcost effectivenesscyclophosphamide/doxorubicin/lomustine protocoldata managementdesignethnic minority populationexpectationexperiencefundamental researchgenetic epidemiologyhealth care deliveryhealth care qualityhealth disparityhuman subjectimprovedinnovationinterestinvestigator traininglecturerlecturesmedical schoolsmedical specialtiesmemberminority healthmortalitymultidisciplinarypatient oriented researchpeerprofessorprogramsprospectiveracial and ethnicrandomized placebo controlled trialremediationresearch studyresponserole modelsafety netskillssocioeconomicssoundstatisticssuccesstext searchingtooltreatment effecttutorial review
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
In response to the RFA-AR-01-009 entitled "Clinical Research Education and Career Development in Minority Institutions", the Charles R. Drew University of Medicine and Science (Drew) is planning to establish a Master of Science in Clinical Research Degree Program (MSCR) through the College of Medicine. This program represents a dramatic advancement as it will become the first independent degree offered through the College of Medicine. Presently, the Doctor of Medicine degree is jointly conferred through Drew's affiliation with the UCLA School of Medicine. This program represents a new curriculum at Drew that will utilize faculty not only from Drew, but also from the affiliated UCLA institutions, including faculty teaching the recently funded UCLA K-30 Translational Research Curriculum Award. The overarching goal is to train qualified candidates in clinical research methodologies and to impart a unique understanding of the cultural and ethical issues that impact how clinical investigation can contribute to improving the health care of our diverse nation. The core curriculum includes areas such as epidemiology, biostatistics, clinical trials, pharmaco-genetics, research ethics, the communication of science, and grantsmanship. The specific aims of the MSCR Program at Drew are to:
1. Implement a new curriculum for patient-oriented research that has a particular emphasis on methodologies to address health disparities.
2. Increase the number of women and ethnic minority investigators well-trained in health disparities research.
3. Develop a cadre of well-trained clinician faculty who will pursue clinical research on diseases that disproportionately affects minority populations.
4. Continuously evaluate the processes and the initial objectives of the MSCR program and utilize these assessments to make ongoing programmatic improvements in consultation with NIH program officials.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
RMCI CLINICAL RESEARCH CENTER INFRASTRUCTURE INITIATIVE: NETWORK CONNECTIVITY
-
批准号:7169101
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2005
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
Charles R Drew University Master of Science and Clinica*
-
批准号:6946858
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2003
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
Charles R Drew University Master of Science and Clinica*
-
批准号:7116915
-
项目类别:
-
资助金额:$52.73万
-
财政年份:2003
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
Charles R Drew University MS and Clinical Res Program
-
批准号:6745390
-
项目类别:
-
资助金额:$53.86万
-
财政年份:2003
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
Charles R Drew University Master of Science and Clinica*
-
批准号:6804598
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2003
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
RMCI Clinical Research Center Infrastructure Initiative*
-
批准号:7126663
-
项目类别:
-
资助金额:$27.5万
-
财政年份:1997
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
RMCI Clinical Research Center Infrastructure Initiative*
-
批准号:7020215
-
项目类别:
-
资助金额:$197.82万
-
财政年份:1997
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
RELATIONSHIP OF AGING, FEVER AND CELL MEDIATED IMMUNITY
-
批准号:3115831
-
项目类别:
-
资助金额:$7.24万
-
财政年份:1985
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
RELATIONSHIP OF AGING, FEVER AND CELL MEDIATED IMMUNITY
-
批准号:3115829
-
项目类别:
-
资助金额:$6.44万
-
财政年份:1985
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
RELATIONSHIP OF AGING, FEVER AND CELL MEDIATED IMMUNITY
-
批准号:3115830
-
项目类别:
-
资助金额:$6.95万
-
财政年份:1985
-
负责人:THOMAS Toyokazu YOSHIKAWA
-
依托单位:
海外基金